Truist Financial Corp Astrazeneca PLC Transaction History
Truist Financial Corp
- $66.7 Billion
- Q2 2025
A detailed history of Truist Financial Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Truist Financial Corp holds 813,753 shares of AZN stock, worth $61.3 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
813,753
Previous 705,491
15.35%
Holding current value
$61.3 Million
Previous $51.9 Million
9.67%
% of portfolio
0.09%
Previous 0.08%
Shares
36 transactions
Others Institutions Holding AZN
# of Institutions
1,413Shares Held
506MCall Options Held
9.17MPut Options Held
3.07M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$3.91 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.1 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.59 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.37 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.35 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...